Exabis Library
Welcome to the e-CCO Library!
DOP78: Intestinal surgery rates in Ulcerative Colitis and Crohn’s Disease in the era of biologics – A Danish Nationwide Register Study from 2003-2016
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP79: Dose escalation of upadacitinib in Crohn’s Disease patients with inadequate response: Data from the randomised CELEST study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP79: Effect of vedolizumab on surgical rates in IBD: Post hoc analysis from the GEMINI trials
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP80: Effectiveness of ustekinumab and vedolizumab in patients with Crohn’s Disease refractory to anti-tumor necrosis factor: A multi-center comparative study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP80: Oral curcumin is not more effective than placebo to prevent endoscopic postoperative recurrence in patients with Crohn's disease treated with concomitant thiopurines: the POPCUR trial.
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP81: Time to loss of efficacy among patients in remission following induction treatment with tofacitinib 10 mg BID who reduced tofacitinib dose or discontinued tofacitinib in OCTAVE Sustain
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP81: Utility of a Simple Blood Test for Mucosal Healing Monitoring is Accurate in Post-Operative Crohn’s Disease
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP82: Direct and indirect costs of inflammatory bowel disease in the biological era; ten years of follow up in a Danish population-based inception cohort
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP82: Macrophages in Crohn’s Disease mesentery are predominantly inflammatory and produce calprotectin
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP83: Association of FUT2 and ABO with Crohn’s disease in Koreans
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP84: Crohn’s Disease modifies the DNA methylome of human adipose-stem cells, which is only partially re-established in remission
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP85: Rising depression and antidepressant use amongst Inflammatory Bowel Disease patients
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP86: Risk for development of inflammatory bowel disease under inhibition of interleukin 17 in psoriasis, psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis: a review and meta-analysis
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP87: Multi-parameter data-sets are required to identify the true prevalence of IBD: The Lothian IBD Registry (LIBDR)
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP87: SUCNR1 a novel key protagonist in fistula development
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP88: Thiopurine and allopurinol combination therapy and the risk of adverse outcomes and step-up medical therapy in Inflammatory Bowel Disease patients: A nationwide Danish cohort study
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP88: Visceral fat area correlates well with anti-TNFα drug levels and secondary loss of response in Crohn’s Disease patients
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP90: The impact of spondyloarthritis and joint symptoms on health-related quality of life and fatigue in IBD. Results after 20 years of follow-up in the IBSEN study.
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
Drugs of the future: Update on developmental agents
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1